Day One Biopharmaceuticals Inc (DAWN)
17.17
-0.40
(-2.28%)
USD |
NASDAQ |
May 03, 16:00
17.15
-0.02
(-0.12%)
After-Hours: 20:00
Day One Biopharmaceuticals Shareholders Equity (Quarterly): 346.54M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 346.54M |
| September 30, 2023 | 389.63M |
| June 30, 2023 | 426.05M |
| March 31, 2023 | 300.42M |
| December 31, 2022 | 332.04M |
| September 30, 2022 | 363.08M |
| June 30, 2022 | 390.63M |
| Date | Value |
|---|---|
| March 31, 2022 | 259.60M |
| December 31, 2021 | 281.15M |
| September 30, 2021 | 297.67M |
| June 30, 2021 | 311.76M |
| March 31, 2021 | -68.85M |
| December 31, 2020 | -54.20M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-68.85M
Minimum
Mar 2021
426.05M
Maximum
Jun 2023
275.04M
Average
311.76M
Median
Jun 2021
Shareholders Equity (Quarterly) Benchmarks
| Revolution Medicines Inc | 1.826B |
| Zentalis Pharmaceuticals Inc | 437.28M |
| Perspective Therapeutics Inc | 75.18M |
| Electromed Inc | 40.34M |
| Xtant Medical Holdings Inc | 51.35M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 376.05M |
| Total Liabilities (Quarterly) | 29.51M |